UBS Group’s Identive INVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.6K Buy
10,165
+6,793
+201% +$27.3K ﹤0.01% 7996
2026
Q1
$12.5K Sell
3,372
-25
-0.7% -$84 ﹤0.01% 8251
2025
Q4
$13K Buy
3,397
+14
+0.4% +$51 ﹤0.01% 8075
2025
Q3
$11.7K Sell
3,383
-36,936
-92% -$132K ﹤0.01% 8472
2025
Q2
$131K Buy
40,319
+2,918
+8% +$9.37K ﹤0.01% 7012
2025
Q1
$119K Sell
37,401
-32,865
-47% -$115K ﹤0.01% 6905
2024
Q4
$257K Buy
70,266
+50,266
+251% +$188K ﹤0.01% 6303
2024
Q3
$70.6K Hold
20,000
﹤0.01% 6592
2024
Q2
$86K Buy
20,000
+17,984
+892% +$85.5K ﹤0.01% 6294
2024
Q1
$16K Sell
2,016
-8,532
-81% -$68K ﹤0.01% 7022
2023
Q4
$86.9K Buy
+10,548
New +$74.4K ﹤0.01% 6249
2023
Q3
Sell
-971
Closed -$8.17K 9702
2023
Q2
$8.17K Sell
971
-6,081
-86% -$41.5K ﹤0.01% 7256
2023
Q1
$43.3K Buy
7,052
+3,562
+102% +$26.2K ﹤0.01% 6565
2022
Q4
$25.3K Buy
3,490
+1,990
+133% +$19.3K ﹤0.01% 7413
2022
Q3
$19K Buy
1,500
+1,371
+1,063% +$18.8K ﹤0.01% 7460
2022
Q2
$1K Sell
129
-2,222
-95% -$27.8K ﹤0.01% 9886
2022
Q1
$38K Sell
2,351
-3,667
-61% -$70.4K ﹤0.01% 6758
2021
Q4
$170K Buy
6,018
+4,393
+270% +$96.5K ﹤0.01% 5837
2021
Q3
$31K Buy
+1,625
New +$27.6K ﹤0.01% 6715
2021
Q2
Sell
-276
Closed -$3K 9576
2021
Q1
$3K Sell
276
-1,308
-83% -$13.4K ﹤0.01% 8518
2020
Q4
$13K Buy
+1,584
New +$10.9K ﹤0.01% 7275
2020
Q3
Sell
-3,088
Closed -$16K 8199
2020
Q2
$16K Buy
+3,088
New +$12.2K ﹤0.01% 6693
2020
Q1
Sell
-4,401
Closed -$25K 8165
2019
Q4
$25K Buy
4,401
+3,901
+780% +$19.7K ﹤0.01% 6749
2019
Q3
$3K Sell
500
-4,643
-90% -$22.9K ﹤0.01% 7635
2019
Q2
$27K Buy
5,143
+1,785
+53% +$8.89K ﹤0.01% 6411
2019
Q1
$17K Sell
3,358
-1,087
-24% -$5.67K ﹤0.01% 6435
2018
Q4
$16K Buy
4,445
+1,963
+79% +$10.5K ﹤0.01% 6943
2018
Q3
$15K Buy
2,482
+1,462
+143% +$8.04K ﹤0.01% 6964
2018
Q2
$4K Buy
1,020
+520
+104% +$1.99K ﹤0.01% 7550
2018
Q1
$2K Sell
500
-1,824
-78% -$6.8K ﹤0.01% 7536
2017
Q4
$8K Buy
2,324
+1,824
+365% +$6.38K ﹤0.01% 7157
2017
Q3
$2K Sell
500
-13,500
-96% -$67.7K ﹤0.01% 7470
2017
Q2
$74K Sell
14,000
-1,579
-10% -$8.99K ﹤0.01% 5374
2017
Q1
$110K Buy
15,579
+1,579
+11% +$7.77K ﹤0.01% 5017
2016
Q4
$45K Sell
14,000
-1,574
-10% -$4.2K ﹤0.01% 5906
2016
Q3
$33K Sell
15,574
-2,979
-16% -$6.11K ﹤0.01% 5837
2016
Q2
$33K Buy
18,553
+14,043
+311% +$31.1K ﹤0.01% 5862
2016
Q1
$10K Buy
4,510
+115
+3% +$229 ﹤0.01% 6665
2015
Q4
$9K Sell
4,395
-3,105
-41% -$8.64K ﹤0.01% 7358
2015
Q3
$26K Sell
7,500
-2,064
-22% -$9.14K ﹤0.01% 6441
2015
Q2
$56K Buy
9,564
+2,094
+28% +$16.5K ﹤0.01% 5911
2015
Q1
$64K Sell
7,470
-1,564
-17% -$18.1K ﹤0.01% 5812
2014
Q4
$126K Buy
+9,034
New +$101K ﹤0.01% 5471

Other funds holding INVE

UBS Group's INVE Position: Q2 2026 in Review

UBS Group increased its Identive (INVE) stake by 201% in Q2 2026, buying an estimated $27.3K and bringing the position to 10,165 shares worth $25.6K. The position accounts for ﹤0.01% of the portfolio, ranked #7996.

UBS Group first reported a position in INVE in Q4 2014 and has held it in 43 quarters since. The position peaked at $257K in Q4 2024. 57 funds tracked by Wall St. Rank hold INVE as of Q2 2026.

  • UBS Group held 10,165 shares of Identive worth $25.6K as of Q2 2026.
  • UBS Group bought 6,793 Identive shares in Q2 2026, an estimated $27.3K.
  • Identive made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #7996 holding.
  • UBS Group first reported a position in Identive in Q4 2014 and has held it in 43 quarters since.
  • UBS Group's Identive position peaked at $257K in Q4 2024.
  • 57 funds tracked by Wall St. Rank held Identive as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.